Painkiller News and Research

RSS

Patients prescribed high doses of pain medications at higher risk of overdose: Study

According to a study published in the April 6 issue of the Journal of the American Medical Association JAMA, receiving higher prescribed doses of opioid prescriptions is associated with an increased risk of opioid overdose death, but receiving both as-needed and regularly scheduled doses is not associated with overdose risk.

5 Apr 2011

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.

4 Apr 2011

Consumption of popular pain reliever during pregnancy may put children at increased risk for asthma

A new study published in the journal Clinical & Experimental Allergy reveals that children whose mothers used the popular pain reliever paracetamol during pregnancy were at an increased risk of wheezing when compared to non-users.

28 Mar 2011

Ibuprofen - painkiller toxicity warning

In a recent development, doctors have warned regarding the possibly toxicities of common pain killer Ibuprofen adding that it can lead to a potentially fatal condition which can be triggered, in rare cases, by even a standard dose. The condition in question is called renal tubular acidosis (RTA). The research is published in the Medical Journal of Australia.

21 Mar 2011

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.

9 Mar 2011

New concerns over prescription narcotics use

Over fifty Australian general practitioners have come under the scanner as part of a national crackdown on inappropriate prescribing of narcotics. The three-month campaign is being carried out by the Medicare following high levels of prescriptions for drugs such as OxyContin and OxyNorm. One GP has been found to be writing over 90 per cent of their prescriptions for narcotics. There are further concerns that the painkillers are being resold on the black market.

7 Mar 2011

QRxPharma granted FDA pre-NDA meeting, further phase II data released

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the granting of a pre-New Drug Application (NDA) meeting with the United States Food and Drug Administration (FDA) and successful completion of its third pivotal Phase 3 registration trial (study 009) for immediate-release MoxDuo.

20 Feb 2011

2007 financial crisis linked to increase in patients seeking treatment for prescription drug and painkiller addiction

The 2007 onset of the financial crisis that upended the U.S. economy and impacted global markets correlated closely with unprecedented numbers of patients seeking treatment for prescription drug addiction and painkiller abuse, according to leading rehabilitation center Cliffside Malibu. The Cliffside Index, the percentage of patients admitted for treatment related to those medications, rose over 60 percent between 2007 and 2008, and has continued to increase each year.

15 Feb 2011

Scientists generate beating heart cells from skin cells of young patients with severe genetic heart defect

Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.

10 Feb 2011

Waismann Method examines link between chronic pain and Opioid-Induced Hyperalgesia

Results from a recent study issued by the Substance Abuse & Mental Health Services Administration revealed that treatment admissions for prescription painkiller abuse rose 345 percent over a 10 year period extending from 1998 to 2008.

5 Feb 2011

Painkillers and heart attack risk

A new study has shown that taking certain commonly used painkillers for long periods or in high doses increases the risk of heart attacks or strokes. The study comes from researchers from Bern University and is published in the British Medical Journal.

16 Jan 2011

FDA calls for cuts in Acetaminophen in painkillers

The US FDA has asked for a limit on the amount of acetaminophen in prescription pain medicines in an effort to reduce the risk of liver damage. The announcement yesterday asked manufacturers to limit combination drugs such as the opioids Percocet and Vicodin to 325 milligrams of acetaminophen per pill and asked them to carry a “black box” warning about potential liver failure. At present these combinations carry up to 750 milligrams of acetaminophen.

13 Jan 2011

NSAIDs raise risk of heart disease: Study

A new study published online in the British Medical Journal explores the relative safety of non-steroidal anti-inflammatory medications (NSAIDs), commonly used to treat joint and muscle aches and pain and concludes that NSAIDs significantly increase the risk of cardiovascular events in patients who take them regularly.

12 Jan 2011

Pain services severely inadequate: report

The Patients Association has urged the Government to create a clear care pathway for chronic pain services throughout the National Health Service. This came in after a survey of more than 4,000 patients revealed significant shortcomings in care.

11 Jan 2011

Games and entertainment for patients in hospitals

The British Medical Association (BMA) says these simple measures can beat boredom and keep patients happy and should be offered by hospitals. The BMA explains that the period of confinement can be a grim experience for some leading to depression. The latest BMA report looks at the emotional needs of patients.

10 Jan 2011

FDA stops pain drug trial over safety concerns

Johnson & Johnson revealed Tuesday this week that a clinical trial of its experimental pain drug, fulranumab, has been stopped after the Food and Drug Administration expressed concerns that patients taking the drug could suffer increased joint damage.

29 Dec 2010

Holder, Sebelius convene day-long summit on health care fraud

High-ranking Obama administration officials are convening a day-long meeting in Massachusetts to brainstorm about ways to prevent health care fraud and abuse. In other news, a federal district judge upholds the prohibition on three former executives from the company that made the painkiller OxyContin — they will continue to be barred from involvement with any government-financed health care program.

17 Dec 2010

Painkiller News and Research

Patients prescribed high doses of pain medications at higher risk of overdose: Study

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

Consumption of popular pain reliever during pregnancy may put children at increased risk for asthma

Ibuprofen - painkiller toxicity warning

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

New concerns over prescription narcotics use

QRxPharma granted FDA pre-NDA meeting, further phase II data released

2007 financial crisis linked to increase in patients seeking treatment for prescription drug and painkiller addiction

Scientists generate beating heart cells from skin cells of young patients with severe genetic heart defect

Waismann Method examines link between chronic pain and Opioid-Induced Hyperalgesia

Painkillers and heart attack risk

FDA calls for cuts in Acetaminophen in painkillers

NSAIDs raise risk of heart disease: Study

Pain services severely inadequate: report

Games and entertainment for patients in hospitals

FDA stops pain drug trial over safety concerns

Holder, Sebelius convene day-long summit on health care fraud

First Edition: December 16, 2010

Using mild painkillers during pregnancy can increase risk of male reproductive disorders

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News